耐受性-话题@MedSci

#耐受性#

144篇内容 | 4038人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1417657, encodeId=c173141e65727, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Respir Med：阿地溴铵/福莫特罗混合剂的长期安全性和耐受性, objectType=article, longId=102482, objectId=fcbd10248200, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcbd10248200, replyNumber=0, likeNumber=75, createdTime=2017-06-21, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcbd10248200, moduleTitle=Respir Med：阿地溴铵/福莫特罗混合剂的长期安全性和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcbd10248200)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417656, encodeId=1aba141e656b1, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=JCEM：作用于胰岛素受体的人单克隆抗体——X358，安全性和耐受性良好, objectType=article, longId=102287, objectId=b21d10228e93, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b21d10228e93, replyNumber=0, likeNumber=96, createdTime=2017-06-19, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b21d10228e93, moduleTitle=JCEM：作用于胰岛素受体的人单克隆抗体——X358，安全性和耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b21d10228e93)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417655, encodeId=d1ce141e65578, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Cell：铁蛋白维持机体血糖促进对于败血症的耐受性, objectType=article, longId=102170, objectId=54571021e049, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54571021e049, replyNumber=0, likeNumber=67, createdTime=2017-06-18, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54571021e049, moduleTitle=Cell：铁蛋白维持机体血糖促进对于败血症的耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54571021e049)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417654, encodeId=9528141e6541c, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Am J Gastroenterol：老年HCV患者无干扰素治疗方案效果及耐受性研究, objectType=article, longId=101550, objectId=7cf610155065, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cf610155065, replyNumber=0, likeNumber=59, createdTime=2017-06-13, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cf610155065, moduleTitle=Am J Gastroenterol：老年HCV患者无干扰素治疗方案效果及耐受性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cf610155065)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417653, encodeId=55b7141e65374, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Aliment Pharm Therap：哪种静脉铁制剂治疗炎性肠病患者缺铁性贫血更具有效性和耐受性？, objectType=article, longId=98524, objectId=b609985241c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b609985241c, replyNumber=0, likeNumber=28, createdTime=2017-05-13, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b609985241c, moduleTitle=Aliment Pharm Therap：哪种静脉铁制剂治疗炎性肠病患者缺铁性贫血更具有效性和耐受性？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b609985241c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417652, encodeId=9f83141e65222, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Sci Rep：治疗帕金森病：10种药物的有效性和耐受性比较, objectType=article, longId=96152, objectId=f3a796152d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3a796152d3, replyNumber=0, likeNumber=75, createdTime=2017-04-19, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3a796152d3, moduleTitle=Sci Rep：治疗帕金森病：10种药物的有效性和耐受性比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3a796152d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417651, encodeId=51db141e6513e, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=JAHA：非瓣膜性房颤患者抗凝治疗大出血并发症和耐受性分析！, objectType=article, longId=89007, objectId=b5268900e06, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5268900e06, replyNumber=0, likeNumber=67, createdTime=2017-02-17, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5268900e06, moduleTitle=JAHA：非瓣膜性房颤患者抗凝治疗大出血并发症和耐受性分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5268900e06)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417650, encodeId=2afb141e6508c, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=BJC：新策略或可有效降低癌细胞对放疗的耐受性, objectType=article, longId=87531, objectId=947f8e53195, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=947f8e53195, replyNumber=0, likeNumber=69, createdTime=2017-01-16, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=947f8e53195, moduleTitle=BJC：新策略或可有效降低癌细胞对放疗的耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=947f8e53195)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417649, encodeId=f9b9141e64912, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Sci Rep：探秘细菌如何对“最后一道防线”抗生素产生耐受性？, objectType=article, longId=87026, objectId=cc758e026bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc758e026bd, replyNumber=0, likeNumber=60, createdTime=2017-01-10, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc758e026bd, moduleTitle=Sci Rep：探秘细菌如何对“最后一道防线”抗生素产生耐受性？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc758e026bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417648, encodeId=035d141e648fc, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=mBio：关键突变让细菌对抗生素产生耐受性, objectType=article, longId=86721, objectId=616b86e2183, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=616b86e2183, replyNumber=0, likeNumber=86, createdTime=2017-01-07, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=616b86e2183, moduleTitle=mBio：关键突变让细菌对抗生素产生耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=616b86e2183)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417647, encodeId=f8c5141e6476e, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=JLR：科学家鉴别出肥胖和胰岛素耐受性的潜在治疗靶点, objectType=article, longId=84734, objectId=638084e347f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=638084e347f, replyNumber=0, likeNumber=75, createdTime=2016-12-21, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=638084e347f, moduleTitle=JLR：科学家鉴别出肥胖和胰岛素耐受性的潜在治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=638084e347f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417646, encodeId=a797141e646f0, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Cell：移除蛋白Gal3或可逆转胰岛素耐受性, objectType=article, longId=81888, objectId=4f2181888df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f2181888df, replyNumber=0, likeNumber=58, createdTime=2016-11-08, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f2181888df, moduleTitle=Cell：移除蛋白Gal3或可逆转胰岛素耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f2181888df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417645, encodeId=e338141e645d1, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=JACC：醛固酮拮抗剂对保留射血分数心衰患者心脏运动耐受性有益, objectType=article, longId=80397, objectId=ee288039ece, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee288039ece, replyNumber=0, likeNumber=67, createdTime=2016-10-21, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee288039ece, moduleTitle=JACC：醛固酮拮抗剂对保留射血分数心衰患者心脏运动耐受性有益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee288039ece)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417644, encodeId=f739141e64408, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Cancer Res：重大突破！特殊蛋白或可恢复耐受性乳腺癌对常见疗法的敏感性, objectType=article, longId=79738, objectId=5efee9738af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5efee9738af, replyNumber=0, likeNumber=55, createdTime=2016-10-12, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5efee9738af, moduleTitle=Cancer Res：重大突破！特殊蛋白或可恢复耐受性乳腺癌对常见疗法的敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5efee9738af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417643, encodeId=e093141e64305, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Cancer：去势耐受性前列腺癌患者肝和/或肺转移后接受enzalutamid治疗效果更好, objectType=article, longId=78936, objectId=4acee8936ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4acee8936ab, replyNumber=0, likeNumber=63, createdTime=2016-09-30, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4acee8936ab, moduleTitle=Cancer：去势耐受性前列腺癌患者肝和/或肺转移后接受enzalutamid治疗效果更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4acee8936ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417642, encodeId=60bf141e64210, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Chest：肺泡II型细胞移植治疗特发性肺纤维化的安全性和耐受性, objectType=article, longId=77992, objectId=ff15e79925f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff15e79925f, replyNumber=0, likeNumber=56, createdTime=2016-09-22, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff15e79925f, moduleTitle=Chest：肺泡II型细胞移植治疗特发性肺纤维化的安全性和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff15e79925f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417641, encodeId=0199141e6410d, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Lancet Oncol：光敏剂TPCS2a安全性和耐受性研究, objectType=article, longId=77079, objectId=c214e70796a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c214e70796a, replyNumber=0, likeNumber=75, createdTime=2016-09-11, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c214e70796a, moduleTitle=Lancet Oncol：光敏剂TPCS2a安全性和耐受性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c214e70796a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417640, encodeId=2866141e640f9, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=Pediatrics：外用马来酸噻吗洛尔治疗婴幼儿血管瘤耐受性和安全性良好, objectType=article, longId=76659, objectId=3d61e6659f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d61e6659f5, replyNumber=0, likeNumber=30, createdTime=2016-09-06, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d61e6659f5, moduleTitle=Pediatrics：外用马来酸噻吗洛尔治疗婴幼儿血管瘤耐受性和安全性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d61e6659f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417639, encodeId=feca141e6399c, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=PLoS Comput Biol：抑制肺癌患者对药物产生耐受性的新策略, objectType=article, longId=76081, objectId=b1b0e60815a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1b0e60815a, replyNumber=0, likeNumber=57, createdTime=2016-08-30, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1b0e60815a, moduleTitle=PLoS Comput Biol：抑制肺癌患者对药物产生耐受性的新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1b0e60815a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1417638, encodeId=9d62141e63853, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, objectTitle=重磅！科学家开发出全球测定HIV药物耐受性突变的新一代测序技术, objectType=article, longId=74533, objectId=f52ee4533a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f52ee4533a8, replyNumber=0, likeNumber=65, createdTime=2016-08-07, rootId=0, userName=Smile2681, userId=43843300457, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f52ee4533a8, moduleTitle=重磅！科学家开发出全球测定HIV药物耐受性突变的新一代测序技术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f52ee4533a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

耐受性

2020-05-29

柳叶一刀 (审核中...)

前往app查看评论内容

#耐受性#

Respir Med：阿地溴铵/福莫特罗混合剂的长期安全性和耐受性

2017-06-21

柳叶一刀 (审核中...)

前往app查看评论内容

#耐受性#

JCEM：作用于胰岛素受体的人单克隆抗体——X358，安全性和耐受性良好

2017-06-19

柳叶一刀 (审核中...)

前往app查看评论内容

#耐受性#

Cell：铁蛋白维持机体血糖促进对于败血症的耐受性

2017-06-18

柳叶一刀 (审核中...)

前往app查看评论内容

#耐受性#

Am J Gastroenterol：老年HCV患者无干扰素治疗方案效果及耐受性研究

2017-06-13

柳叶一刀 (审核中...)

前往app查看评论内容

#耐受性#

Aliment Pharm Therap：哪种静脉铁制剂治疗炎性肠病患者缺铁性贫血更具有效性和耐受性？

2017-05-13

柳叶一刀 (审核中...)

前往app查看评论内容

#耐受性#

Sci Rep：治疗帕金森病：10种药物的有效性和耐受性比较

2017-04-19

柳叶一刀 (审核中...)

前往app查看评论内容

#耐受性#

JAHA：非瓣膜性房颤患者抗凝治疗大出血并发症和耐受性分析！

2017-02-17

柳叶一刀 (审核中...)

前往app查看评论内容

#耐受性#

BJC：新策略或可有效降低癌细胞对放疗的耐受性

2017-01-16

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Sci Rep：探秘细菌如何对“最后一道防线”抗生素产生耐受性？

2017-01-10

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

mBio：关键突变让细菌对抗生素产生耐受性

2017-01-07

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

JLR：科学家鉴别出肥胖和胰岛素耐受性的潜在治疗靶点

2016-12-21

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Cell：移除蛋白Gal3或可逆转胰岛素耐受性

2016-11-08

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

JACC：醛固酮拮抗剂对保留射血分数心衰患者心脏运动耐受性有益

2016-10-21

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Cancer Res：重大突破！特殊蛋白或可恢复耐受性乳腺癌对常见疗法的敏感性

2016-10-12

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Cancer：去势耐受性前列腺癌患者肝和/或肺转移后接受enzalutamid治疗效果更好

2016-09-30

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Chest：肺泡II型细胞移植治疗特发性肺纤维化的安全性和耐受性

2016-09-22

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Lancet Oncol：光敏剂TPCS2a安全性和耐受性研究

2016-09-11

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

Pediatrics：外用马来酸噻吗洛尔治疗婴幼儿血管瘤耐受性和安全性良好

2016-09-06

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

PLoS Comput Biol：抑制肺癌患者对药物产生耐受性的新策略

2016-08-30

Smile2681 (审核中...)

前往app查看评论内容

#耐受性#

重磅！科学家开发出全球测定HIV药物耐受性突变的新一代测序技术

2016-08-07

科室
- - 订阅+
  - 更多科室
工具
服务